Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Civeo Corp (CVEO)

Civeo Corp (CVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Civeo: Q3 Earnings Snapshot

Civeo: Q3 Earnings Snapshot

CVEO : 21.43 (-1.20%)
Civeo: Q2 Earnings Snapshot

Civeo: Q2 Earnings Snapshot

CVEO : 21.43 (-1.20%)
Civeo: Q1 Earnings Snapshot

Civeo: Q1 Earnings Snapshot

CVEO : 21.43 (-1.20%)
Civeo: Q4 Earnings Snapshot

Civeo: Q4 Earnings Snapshot

CVEO : 21.43 (-1.20%)
Civeo: Q3 Earnings Snapshot

Civeo: Q3 Earnings Snapshot

CVEO : 21.43 (-1.20%)
Civeo: Q2 Earnings Snapshot

Civeo: Q2 Earnings Snapshot

CVEO : 21.43 (-1.20%)
Civeo: Q1 Earnings Snapshot

Civeo: Q1 Earnings Snapshot

CVEO : 21.43 (-1.20%)
Civeo Reports First Quarter 2023 Results

Civeo Corporation (NYSE:CVEO) today reported financial and operating results for the first quarter ended March 31, 2023.

CVEO : 21.43 (-1.20%)
Civeo Announces First Quarter 2023 Earnings Conference Call

Civeo Corporation (NYSE:CVEO) announced today that it has scheduled its first quarter 2023 earnings conference call for Friday, April 28, at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). During the...

CVEO : 21.43 (-1.20%)
Civeo: Q4 Earnings Snapshot

Civeo: Q4 Earnings Snapshot

CVEO : 21.43 (-1.20%)

Barchart Exclusives

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases
The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar